Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Colorcon
Mallinckrodt
Harvard Business School

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR VINORELBINE TARTRATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Vinorelbine Tartrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002813 ↗ Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer Completed National Cancer Institute (NCI) Phase 2 1997-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.
NCT00002813 ↗ Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer Completed Gynecologic Oncology Group Phase 2 1997-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.
NCT00002823 ↗ Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer Completed Gustave Roussy, Cancer Campus, Grand Paris Phase 3 1995-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.
NCT00002887 ↗ Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer Unknown status Ottawa Regional Cancer Centre Phase 1 1995-07-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells. PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer.
NCT00002949 ↗ Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis Completed National Cancer Institute (NCI) Phase 1 1996-07-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy with may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy with vinorelbine and paclitaxel plus radiation therapy in treating patients with advanced cancer arising in the pelvis.
NCT00002949 ↗ Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis Completed University of Chicago Phase 1 1996-07-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy with may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy with vinorelbine and paclitaxel plus radiation therapy in treating patients with advanced cancer arising in the pelvis.
NCT00003159 ↗ Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer Completed European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1997-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if surgery is more effective with or without preoperative chemotherapy in treating non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying surgery and preoperative chemotherapy to see how well they work compared to surgery alone in treating patients with resectable non-small cell lung cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vinorelbine Tartrate

Condition Name

Condition Name for Vinorelbine Tartrate
Intervention Trials
Lung Cancer 22
Breast Cancer 11
Lymphoma 5
Prostate Cancer 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Vinorelbine Tartrate
Intervention Trials
Lung Neoplasms 28
Carcinoma, Non-Small-Cell Lung 26
Breast Neoplasms 19
Hodgkin Disease 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Vinorelbine Tartrate

Trials by Country

Trials by Country for Vinorelbine Tartrate
Location Trials
United States 570
Canada 51
Australia 18
United Kingdom 18
Italy 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Vinorelbine Tartrate
Location Trials
California 24
Illinois 22
New York 22
Florida 18
Texas 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Vinorelbine Tartrate

Clinical Trial Phase

Clinical Trial Phase for Vinorelbine Tartrate
Clinical Trial Phase Trials
Phase 3 19
Phase 2/Phase 3 2
Phase 2 41
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Vinorelbine Tartrate
Clinical Trial Phase Trials
Completed 46
Unknown status 15
Terminated 11
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Vinorelbine Tartrate

Sponsor Name

Sponsor Name for Vinorelbine Tartrate
Sponsor Trials
National Cancer Institute (NCI) 34
Children's Oncology Group 6
Alliance for Clinical Trials in Oncology 5
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Vinorelbine Tartrate
Sponsor Trials
Other 84
NIH 35
Industry 18
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
Express Scripts
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.